Cervical laminoplasty is a well-established surgical approach for managing various cervical spine pathologies, including cervical spondylotic myelopathy, spinal canal stenosis, and ossification of the posterior longitudinal ligament. Among the available laminoplasty techniques, the use of Hydroxyapatite spacers secured with screws is common for maintaining the expanded interlaminar space. However, one potential complication is screw back-out, which, although recognized, has rarely been documented in the literature. We present a rare case of delayed screw migration culminating in skin perforation in a 76-year-old woman who underwent cervical laminoplasty for cervical spondylotic myelopathy. During the index procedure, Hydroxyapatite spacers were placed and secured with screws into the lamina. Seven years postoperatively, gradual subcutaneous migration of the screw from the lamina of the fourth cervical vertebra was observed, ultimately resulting in complete skin penetration 9 years after the initial surgery. The patient underwent surgical removal of the protruding screw along with surrounding granulation tissue. The surgical site was thoroughly irrigated with copious saline, and the wound was closed primarily with sutures. Postoperative recovery was uneventful. Stitches were removed on day 11 after confirming complete wound healing. This case underscores an exceptionally rare but clinically significant late complication of cervical laminoplasty with Hydroxyapatite spacers -complete screw extrusion through the skin. To our knowledge, this is the first documented case of its kind. The prolonged asymptomatic nature of screw migration in this patient highlights the importance of long-term surveillance following laminoplasty, even in the absence of clinical symptoms, to detect hardware-related complications at an early stage.

Solitary plasmacytoma is a hematologic malignancy in which about 50% of cases progress to multiple myeloma within 10 years. Local radiation therapy is effective for solitary plasmacytoma treatment, but there are cases of spinal cord paralysis due to osteolytic pathological fractures in the spine. Here, we report a 63-year-old male with spinal cord injury caused by pathologic fracture progression after radiotherapy. A 63-year-old male presented with neck pain and left hemiplegia. Imaging studies revealed a pathological fracture of the C5 vertebral body, and biopsy confirmed the diagnosis of solitary plasmacytoma. Radiation therapy temporarily improved symptoms, but progressive quadriplegia developed 2 months later. Cervical spinal cord compression due to an additional vertebral bone fracture was confirmed. Aggressive lesionectomy and fixation using simultaneous anterior and posterior combined approaches were performed. Postoperatively, paralysis completely recovered. No local recurrence or transition to multiple myeloma was observed even after 7 years of follow-up at age 70. Surgical treatment may be effective for spinal cord injury associated with pathologic fracture progression after radiotherapy for solitary plasmacytoma.

Flow diverters have revolutionized the treatment of large and giant cerebral aneurysms. However, aneurysms with branch vessels originating from the aneurysm sac remain challenging for flow diverter monotherapy. We present five cases demonstrating favorable outcomes following combined treatment with overlapping flow diverter with coiling. The study cohort included five female patients with a mean age of 72.8 years. The mean aneurysm diameter was 8.1 mm. Triple antithrombotic therapy (dual antiplatelet therapy plus short-term anticoagulation) was administered to prevent ischemic complications due to posterior communicating artery occlusion in the perioperative period. Complete or near-complete occlusion (O'Kelly-Marotta grade C or D) was achieved in all cases. Follow-up angiography (mean follow-up time: 17.2 months) revealed preserved patency of the posterior communicating artery in four of five cases. In one case, the posterior communicating artery arising from the aneurysm was occluded at its origin but was supplied retrograde from the posterior circulation. Follow-up digital subtraction angiography of most cases showed caliber changes, with the posterior communicating artery diameter reducing and the P1 segment of the posterior cerebral artery increasing. No ischemic or hemorrhagic complications occurred perioperatively or during follow-up. Overlapping flow diverter with coiling combined with low-dose and short-term triple antithrombotic therapy might be a safe and effective treatment for fetal-type posterior communicating artery aneurysms, offering a viable alternative for complex aneurysms. Further studies with long-term follow-up data from a larger patient cohort are required to validate the efficacy and safety demonstrated in this case series.

To investigate whether oral contraceptives induce acute ischemic stroke in patients with moyamoya disease. We retrospectively reviewed female patients with moyamoya disease who were taking oral contraceptives during their reproductive years (12-49 years of age) at the time of diagnosis or during follow-up. The patients' detailed clinical history, including the time course of oral contraceptive usage and acute ischemic stroke occurrence, was evaluated. For patients with radiological evidence of acute ischemic stroke, the imaging pattern of stroke was assessed to investigate the underlying mechanisms. Among 589 female patients, 12 patients took oral contraceptives at some point during the period from 2012 to 2023; 5 patients were taking oral contraceptives at the time of diagnosis, and 4 of them were diagnosed with moyamoya disease after acute ischemic stroke. Among the 7 patients who started oral contraceptives during follow-up, 2 patients developed acute ischemic stroke several months after starting oral contraceptives. Notably, none of the hemispheres that developed acute ischemic stroke previously underwent revascularization, and none of the 5 hemispheres with prior revascularization developed acute ischemic stroke. The imaging pattern of acute ischemic stroke in 7 patients suggested the contribution of a thromboembolic mechanism. Oral contraceptives may increase the risk of acute ischemic stroke via thromboembolic mechanisms in patients with moyamoya disease, but its risk might be manageable in hemispheres with prior revascularization and stable disease conditions for years. Active education of patients regarding the possible risk of oral contraceptives and close communication with gynecologists seem necessary to provide the best treatment strategies for female patients with moyamoya disease who require contraception or treatment of menstrual disorders.